Cargando…

Remdesivir for COVID-19: challenges of underpowered studies

Detalles Bibliográficos
Autor principal: Norrie, John David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190306/
https://www.ncbi.nlm.nih.gov/pubmed/32423580
http://dx.doi.org/10.1016/S0140-6736(20)31023-0
_version_ 1783527664986882048
author Norrie, John David
author_facet Norrie, John David
author_sort Norrie, John David
collection PubMed
description
format Online
Article
Text
id pubmed-7190306
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71903062020-04-30 Remdesivir for COVID-19: challenges of underpowered studies Norrie, John David Lancet Comment Elsevier Ltd. 2020 2020-04-29 /pmc/articles/PMC7190306/ /pubmed/32423580 http://dx.doi.org/10.1016/S0140-6736(20)31023-0 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Comment
Norrie, John David
Remdesivir for COVID-19: challenges of underpowered studies
title Remdesivir for COVID-19: challenges of underpowered studies
title_full Remdesivir for COVID-19: challenges of underpowered studies
title_fullStr Remdesivir for COVID-19: challenges of underpowered studies
title_full_unstemmed Remdesivir for COVID-19: challenges of underpowered studies
title_short Remdesivir for COVID-19: challenges of underpowered studies
title_sort remdesivir for covid-19: challenges of underpowered studies
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190306/
https://www.ncbi.nlm.nih.gov/pubmed/32423580
http://dx.doi.org/10.1016/S0140-6736(20)31023-0
work_keys_str_mv AT norriejohndavid remdesivirforcovid19challengesofunderpoweredstudies